- Proposed acquisition of Glenwood Private Equity’s 54% stake in the listed South Korean company PI Advanced Materials (PIAM), for €728m enterprise value. The company will be fully consolidated in Arkema’s accounts
- With sales of over €200m, an EBITDA margin of around 30% and best-in-class manufacturing, PIAM is the global leader in polyimide films, delivering superior growth in the attractive consumer electronics and electric vehicles markets
- New significant milestone in Arkema’s transformation into a pure Specialty Materials player
- Rare opportunity to broaden Arkema’s polymer range with an ultra-high performance and cutting-edge technology, strengthening the Advanced Materials segment’s portfolio and performance
- PIAM’s sales expected to grow at 13% p.a., driven by unique opportunities for polyimide in increasingly demanding applications such as lithium-ion batteries, 5G antennas, high resolution OLED displays or flexible screens, and supported by recent capacity expansions
- Valuation representing c.20x the average 2021/2022 EBITDA, and targeting 8x 2027 estimated EBITDA, post synergies evaluated at €30 million
- Transaction fully financed in cash, maintaining a strong balance sheet with a net debt on EBITDA ratio within Arkema’s financial leverage objective of 2x
PIAM is an outstanding company with a unique technological positioning, state of the art manufacturing facilities and invaluable customer relationships. This acquisition is fully aligned with our strategy to be at the forefront of high performance materials for high growth end markets supported by megatrends such as electric vehicles and advanced electronics.
After the divestment of PMMA, the acquisition of Ashland adhesives and the current start-up of our bio PA11 plant in Singapore, Arkema is delivering another significant milestone of its strategy focused on innovative materials for a sustainable world."
A key milestone in the strengthening of Arkema’s advanced materials segment
PIAM’s ultra-high performance polyimides are cutting-edge materials offering exceptionally high temperature resistance, dimensional stability, flexibility and electric insulation. They are increasingly used in attractive markets such as electric vehicles, consumer electronics, semiconductor manufacturing and other advanced industrial applications. They benefit from the growing need for miniaturization, higher thermal management and increased safety and durability.
With two state-of-the-art industrial production sites and two R&D centers in South Korea, this highly innovative company employs approximately 320 people. PIAM enjoyed strong sales growth of 12% per year on average in the 2012-2021 period, focusing on top quality and high value added products, and reaching an EBITDA margin of 30%. Sales amounted to around €200 million in 2022, temporarily impacted by the large destocking observed in the global consumer electronics market.
mid term developments.
The acquisition of Glenwood Private Equity’s 54% controlling stake will allow the full consolidation of PIAM in Arkema’s accounts. The remaining 46% of the shares will continue to be listed on the Korean stock exchange.
PIAM’s portfolio fits perfectly with the Advanced Materials segment, strengthening the high performance polymer range in attractive markets linked to megatrends, and enabling to accelerate the segment’s organic sales growth and expand its EBITDA margin.
A deal fully in line with Arkema’s strategy and offering strong synergies
The project offers significant pre-tax synergies estimated at around €30 million at the EBITDA level, which should be progressively achieved within the next five years, with a limited requirement for additional capital expenditure. These synergies are driven by the perfect complementarities of product ranges, Arkema’s geographic reach and PIAM’s strong customer intimacy in Asia.
The transaction price is based on a €728 million enterprise value for the 54% stake, representing c.20x the average 2021/2022 EBITDA. The enterprise value/EBITDA multiple will be reduced to 8x in 2027 with the benefit of PIAM’s organic growth and of the targeted synergies and will continue to decrease over the following years. The deal will be financed fully in cash, maintaining a strong balance sheet with a level of net debt including hybrid bonds that will stay within Arkema’s financial leverage objective of 2x EBITDA.
Following this transaction and all that has been achieved over the past years in both organic projects and M&A, Arkema’s technological profile will now be uniquely positioned to benefit from the accelerating demand linked to megatrends. In the coming years, the Group will give its priority to organic growth, leveraging its breadth of innovative technologies in attractive markets and applications. With regard to M&A, the Group will continue to work on the deconsolidation of its Intermediates segment and will focus its acquisitions program on
bolt-on operations, particularly in adhesives.
The deal, which is subject to the approval of Chinese and Korean anti-trust authorities, should be finalized end-2023.